Iran medicine shortages and hyperinflation force patients to abandon critical treatments

Severe medicine shortages and hyperinflation in Iran have rendered essential treatments, such as chemotherapy, financially inaccessible for the average citizen. The crisis is forcing a significant portion of the population to delay or cease medical care, highlighting the failure of domestic supply chains and the impact of economic instability on public health outcomes.